Aller au contenu

FLGR-242 – The Muscle Building Compound That’s Changing Everything Pt. 2 | Peptide of the Week Pod

4 novembre 2026 · 39 min

Notes de l’épisode

Follow us on social media:

JD's Socials: https://hoo.be/jddenhamofficial

Will's Socials: https://hoo.be/williamthaas

Peptide Of The Week Socials: https://hoo.be/peptideoftheweekpodcast


Join The Community: https://www.skool.com/peptideresearchinstitute/about


Subscribe to our Newsletter: https://potwnewsletter.beehiiv.com/


Warrior Coaching: https://www.warrior-makerscoaching.com


Peptide Of The Week Website: https://peptideoftheweekpod.com


Medical Disclaimer: We are not doctors. The content in this video is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Any compounds discussed may be intended for research purposes only. Use at your own risk.


Part two with Michael Farber goes deep on FLGR-242, the long acting myostatin inhibitor he invented that is helping people gain 10 to 12 pounds of lean muscle in three to four months, without anabolics, without side effects, and regardless of genetics. This is one of the most important muscle building conversations we have ever had on this podcast.


🔬 Topics Covered:

• Why Farber invented FLGR-242 after losing 2+ years of muscle during COVID

• What myostatin actually is and why it is your body's brake on muscle growth and fat burning

• Belgian blue cows, super mice, and real world examples of myostatin mutations

• Why naturally gifted athletes often have partial myostatin mutations and do not even know it

• How FLGR-242 levels the playing field for people not born with athletic genetics

• Expected results: 10 to 12 pounds of lean muscle in 3 to 4 months at 5mg per week

• Why going above 10mg per week produces virtually no additional gains

• Farber personally went to 20mg per week and confirmed no negative health effects above 10mg

• How FLGR-242 was designed to bind ONLY myostatin and why that makes it so safe

• Why Follistatin-344 causes random growth and must be injected locally while FLGR-242 freely circulates

• Brian Johnson's myostatin experiment in Honduras: 2% gain in a year at $50,000 per try

• FLGR-242 vs circular DNA myostatin inhibitors: not even close

• Apelin-13: the ergogenic compound that optimizes fat burning and cardiovascular output simultaneously

• Long acting Thymosin Alpha-1 and Thymosin Beta coming soon

• Bioline: the new appetite and metabolism compound coming down the pipeline

• The albumin binder platform and why it is changing how every compound performs


Chapters:

00:00 – Intro

00:09 – Welcome Back & Will's Mom Moving to Town

01:24 – Appreciating Your Parents While You Have Them

03:29 – Round Two With Michael Farber: Why He Created FLGR-242

06:27 – Myostatin Inhibition Beyond Muscle: Obesity & Fetal Growth

10:02 – Leveling the Playing Field for Natural Athletes

12:21 – Real-World Results: 10–12 Pounds of Lean Muscle in 4 Months

14:44 – Dosing: Why More Than 10 mg a Week Doesn't Help

19:23 – How FLGR-242 Differs From Follistatin 344

24:06 – Safety Record & Gene Therapy Alternatives

27:55 – What's Next: Apelin, Long-Acting Thymosin & Obesity Compounds

30:16 – The Albumin Binder Discovery: MC4R & Amylin Compounds

34:34 – Cancer Drug Trojan Horse Idea

36:40 – Upcoming Launches: Appetite Control & Long-Acting Thymosin Alpha-1

38:44 – Outro

Tous les épisodes de Peptide of The Week

Paramètres

Affichage

Langue

Détermine les stations affichées en premier sur la page d’accueil.

Historique

Les stations et épisodes écoutés récemment et tes dernières recherches sont seulement enregistrés dans ce navigateur.

Notifications

Un court message quand un podcast que tu suis publie un nouvel épisode. Désactive un podcast précis avec la cloche sur sa page.

Compte

Enregistrez vos favoris – dans l’app et sur le site.

Raccourcis clavier

/
Ouvrir la recherche
Espace
Lecture ou pause
← →
Dans le lecteur : 15 s en arrière, 30 s en avant (épisodes) · dans une rangée : tuile suivante
↑ ↓
Dans une rangée : cible dans la tuile
Début / Fin
Dans une rangée : première ou dernière tuile
Esc
Fermer la fenêtre ou le menu
?
Cet aperçu
En cours de lecture

Voir la station

À suivre

    Ajoutez des épisodes avec « À suivre » – ils seront lus après l'épisode en cours.